ENDRA Life Sciences- Warrants (12/05/2022) Total Current Liabilities

As of the most recent data (March 2026), NDRAW shows a total current liabilities of $840K. That compares with $570K in the prior-year period — up 47.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, NDRAW's total current liabilities is now $840K (was $570K) — a 47.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ENDRA Life Sciences- Warrants (12/05/2022) is outperforming or lagging.

Tracking NDRAW's total current liabilities over time shows whether ENDRA Life Sciences- Warrants (12/05/2022) is scaling, shrinking, or reshaping that part of the business. The current reading is $840K That compares with $570K in the prior-year period — up 47.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total current liabilities page, Stockcircle has ENDRA Life Sciences- Warrants (12/05/2022)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $840K) with ownership activity and broader fundamentals.

ENDRA Life Sciences- Warrants (12/05/2022)'s total current liabilities is $840K; compare it with other Technology names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.